跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞舒伐他汀依折麦布片(Ⅰ) - NMPA Drug Approval Details
Approvals
/
NMPA
/
Rosuvastatin Calcium and Ezetimibe Tablets (I)
Approved
化学药品
Rosuvastatin Calcium and Ezetimibe Tablets (I)
Sanofi-aventis Ireland Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Dec 26, 2023
Approval ID
8WHZLT0SSMf
Company
Sanofi-aventis Ireland Ltd.
Type
化学药品
Approval Details
Approval Id
8WHZLT0SSMf
Approval Number
国药准字HJ20230147
Generic Name
瑞舒伐他汀依折麦布片(Ⅰ)
Generic Name En
Rosuvastatin Calcium and Ezetimibe Tablets (I)
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含瑞舒伐他汀钙10mg(按瑞舒伐他汀计)与依折麦布10mg。
Reg Date
2023-12-26
Expired Date
2028-12-25
Company Name
Sanofi-aventis Ireland Ltd.
Production Company Name
SANOFI ILAC SANAYI VE TICARET ANONIM SIRKETI
Company Detail Path
/organization/sanofi-aventis-ireland-ltd
Production Company Detail Path
/organization/sanofi-ilac-sanayi-ve-ticaret-anonim-sirketi
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 26, 2023
Approval ID
8WHZLT0SSMf
Type
化学药品
Back to NMPA Approvals